Perioperative pembrolizumab in early-stage non-small cell lung cancer (NSCLC): safety, efficacy, and exploratory biomarker analysis — C. G. Wood (2025) | RDL Network
Jingxuan Zhang, Lin Lin, Jennifer Enzor, Prekshaben Patel, Katelyn N. Steadman, V I Little, Lin Gu, Eziafa Oduah, Betty Tong, Scott Antonia, Neal Ready, Kent J. Weinhold
Hirva Mamdani, Jeffrey Clarke, Lin Gu, Tom Stinchcombe, Jeffrey Crawford, Scott Antonia, Michael J. Campa, Andrew B. Nixon, Guru Sonpavde, George R. Simon, Neal Ready, JAMES E HERNDON, Edward F. Patz
P. Kosmidis, Eleni Timotheadou, Αngelos Koutras, George Pentheroudakis, C. Christodoulou, Meletios A Dimopoulos, D. Bafaloukos, E. Samantas, Dimitrios Pectasides, K. Syrigos
Yichen Guo, Ruyang Zhang, Sipeng Shen, Yongyue Wei, Sebastian Moran Salama, Thomas Fleischer, Maria Moksnes Bjaanæs, Anna Karlsson, Maria Planck, Li Su, Zhaozhong Zhu, Johan Staaf, Åslaug Helland, Manel Esteller, David C. Christiani
Antonio Palumbo, Meletios A Dimopoulos, Michel Delforge, Martin Kropff, Robin Foà, Zhinuan Yu, Lindsay Herbein, Jay Mei, Christian Jacques, John Catalano
Discussion(0)
No comments yet. Be the first to comment.